Prosecution Insights
Prosecution Insights
33 pending office actions • 24 art units • 33 examiners • 2 of 33 (6%) have an AI response strategy ready • 13 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (3%) |
| §103 only | 13 (39%) |
| §102 only | 2 (6%) |
| §112 only | 4 (12%) |
| Double-patenting only | 1 (3%) |
| Double-patenting + other | 6 (18%) |
| Multi-statute (no §101) | 5 (15%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCHARCZK, JED A | 1 | 79.6% | +16.9% |
| BAEK, BONG-SOOK | 1 | 41.7% | +69.8% |
| WILSON, JERICA KATLYNN | 1 | 61.5% | +38.7% |
| PACKARD, BENJAMIN J | 1 | 66.5% | +15.7% |
| ARCORIA, PAUL JOSEPH | 1 | — | — |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
| AL-AWADI, DANAH J | 1 | 54.0% | +13.7% |
| SONG, JIANFENG | 1 | 56.2% | +33.1% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.5% | +20.8% |
| AULAKH, CHARANJIT | 1 | 80.8% | -15.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573785 | COMPOSITION FOR SUPPRESSING MUSCLE DAMAGE | AULAKH, CHARANJIT | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | LANDAU, SHARMILA GOLLAMUDI | 142d overdue |
| 17924232 | MODELED OBJECT AND METHOD FOR PRODUCING SAME | GROUX, JENNIFER LILA | 26d overdue |
| 18840444 | COMBINATION FORMULATION OF CEDAZURIDINE | PACKARD, BENJAMIN J | — |
| 18720446 | COMPOSITION FOR IMPROVING SLEEP QUALITY OR CONTROLLING AUTONOMIC NERVOUS SYSTEM | ARCORIA, PAUL JOSEPH | — |
| 18839933 | SYRINGE FOR CRYOPRESERVATION | NGO, MEAGAN N | — |
| 18627228 | CONTENT PROCESSING METHOD AND COMPUTER-READABLE MEDIUM | WEAVER, ADAM MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19220457 | METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS | KUCHARCZK, JED A | 46d overdue |
| 18907757 | COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER | BAEK, BONG-SOOK | — |
| 18814803 | 4-(METHYLAMINOPHENOXY)PYRDIN-3-YL-BENZAMIDE DERIVATIVES FOR TREATING CANCER | WILSON, JERICA KATLYNN | — |
| 18840444 | COMBINATION FORMULATION OF CEDAZURIDINE | PACKARD, BENJAMIN J | — |
| 18744247 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | MCINTOSH III, TRAVISS C | — |
| 18662049 | INJECTABLE PREPARATION | AL-AWADI, DANAH J | — |
| 18702752 | COMPOSITIONS COMPRISING AN ERK INHIBITOR | SONG, JIANFENG | — |
| 18689319 | ACRIDINE COMPOUND | MAHLUM, JONATHAN DAVIS | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1621 | 2 |
| 1623 | 1 |
| 1693 | 1 |
| 1613 | 1 |
| 1625 | 1 |
| 1627 | 1 |
| 1622 | 1 |
| 1629 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19220457 | METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS | KUCHARCZK, JED A | 1623 | §103DP | Final Rejection | 46d overdue | AI Ready | May 28, 2025 |
| 18907757 | COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER | BAEK, BONG-SOOK | — | §102§103DP | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18814803 | 4-(METHYLAMINOPHENOXY)PYRDIN-3-YL-BENZAMIDE DERIVATIVES FOR TREATING CANCER | WILSON, JERICA KATLYNN | — | §103 | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18840444 | COMBINATION FORMULATION OF CEDAZURIDINE | PACKARD, BENJAMIN J | — | §102§103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18720446 | COMPOSITION FOR IMPROVING SLEEP QUALITY OR CONTROLLING AUTONOMIC NERVOUS SYSTEM | ARCORIA, PAUL JOSEPH | — | §102§103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18744247 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | MCINTOSH III, TRAVISS C | 1693 | DP | Final Rejection | — | Pending | Jun 14, 2024 |
| 18662049 | INJECTABLE PREPARATION | AL-AWADI, DANAH J | 1615 | §112DP | Non-Final OA | — | Pending | May 13, 2024 |
| 18702752 | COMPOSITIONS COMPRISING AN ERK INHIBITOR | SONG, JIANFENG | 1613 | — | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18689319 | ACRIDINE COMPOUND | MAHLUM, JONATHAN DAVIS | 1625 | §102 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18573785 | COMPOSITION FOR SUPPRESSING MUSCLE DAMAGE | AULAKH, CHARANJIT | 1621 | §103 | Final Rejection | — | Pending | Dec 26, 2023 |
| 18561602 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS | RAO, PADMAJA S | 1627 | §112 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18548522 | BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS | ELENISTE, PIERRE PAUL | 1622 | §103§112DP | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18546602 | AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM | SASAN, ARADHANA | 1615 | §103 | Non-Final OA | 26d | Pending | Aug 16, 2023 |
| 18042503 | CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND | SHOWALTER, ALEXANDER KEITH | 1629 | §112Other | Final Rejection | 60d overdue | Pending | Feb 22, 2023 |
| 17923188 | IAP ANTAGONIST COMPOUNDS AND INTERMEDIATES AND METHODS FOR SYNTHESIZING THE SAME | O DELL, DAVID K | 1621 | §103 | Final Rejection | — | Pending | Nov 03, 2022 |
| 17923182 | METHODS FOR SYNTHESIZING ANHYDROUS LACTIC ACID | BAZARGANI, ARYA AHMADI | 1600 | §112 | Non-Final OA | — | Pending | Nov 03, 2022 |
| 17757843 | BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS | LEE, CHIHYI NMN | 1628 | §103§112DP | Final Rejection | — | Pending | Jun 22, 2022 |
| 17755832 | ORALLY DISINTEGRATING TABLET | PALENIK, JEFFREY T | 1614 | §103 | Non-Final OA | — | AI Ready | Jun 10, 2022 |
| 17782469 | STANDARD SUBSTANCE FOR PSA QUANTIFICATION, PREPARATION METHOD THEREFOR, STANDARD SOLUTION FOR PSA QUANTIFICATION, AND PSA QUANTIFICATION METHOD | DEBERRY, REGINA M | 1647 | §103 | Non-Final OA | — | Pending | Jun 03, 2022 |
| 17616921 | TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE | STOCKTON, LAURA LYNNE | 1626 | §112 | Non-Final OA | — | Pending | Dec 06, 2021 |
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103§112 | Final Rejection | 142d overdue | Pending | Apr 30, 2020 |
| 18855167 | MAMMALIAN CELL CRYOPRESERVATION LIQUID | THUESON, HANNA MARIE | — | §103 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18839933 | SYRINGE FOR CRYOPRESERVATION | NGO, MEAGAN N | — | §102§103 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18576582 | ENTERAL NUTRIENT PREPARATION | O'HERN, BRENT T | 1658 | §102 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18284014 | MULTILAYER FILM AND LIQUID AGENT CONTAINER | CHEN, VIVIAN | 1787 | §103 | Final Rejection | — | Pending | Sep 25, 2023 |
| 17793611 | METHOD OF PRODUCING CAPSULE COMPRISING PANCREATIC ISLET | ZHANG SPIERING, DONGXIU | 1616 | §103DP | Non-Final OA | — | Pending | Jul 18, 2022 |
| 17438025 | STORAGE LIQUID FOR MAMMALIAN CELLS | REGLAS, GEORGIANA C | 1651 | §103 | Final Rejection | 97d overdue | Pending | Sep 10, 2021 |
| 16645213 | STEM CELL DERIVED FROM NEONATAL PIG AND METHOD FOR PRODUCING SAME | NGUYEN, QUANG | 1631 | §103 | Final Rejection | 38d overdue | Pending | Mar 06, 2020 |
| 18627228 | CONTENT PROCESSING METHOD AND COMPUTER-READABLE MEDIUM | WEAVER, ADAM MICHAEL | 2658 | §101§103 | Final Rejection | — | Pending | Apr 04, 2024 |
| 18574520 | RUBBER COMPOSITION AND TIRE | FISCHER, JUSTIN R | 1749 | §103 | Non-Final OA | 12d | Pending | Dec 27, 2023 |
| 18563617 | EPOXY RESIN MODIFIER, EPOXY RESIN COMPOSITION CONTAINING SAME, ADHESIVE COMPOSED OF EPOXY RESIN COMPOSITION, AND RESIN CURED PRODUCT OBTAINED BY CURING EPOXY RESIN COMPOSITION | ZHANG, RUIYUN | — | §103 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18039854 | TITANIC ACID-BASED SOLID ELECTROLYTE MATERIAL | HANSEN, JARED A | 1723 | §103 | Final Rejection | 34d | Pending | Jun 01, 2023 |
| 17924232 | MODELED OBJECT AND METHOD FOR PRODUCING SAME | GROUX, JENNIFER LILA | 1754 | §103§112 | Non-Final OA | 26d overdue | Pending | Nov 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial